ERIS Share Price Performance
₹0
-1541.40 (-100.00%)
Price ₹0
Fair Value₹1,712.60
Share Pricen/a
Analysis Article • May 23
Eris Lifesciences Limited Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 7 Fair Values set on narratives written by author
ERIS Community Narratives
AN
Fair Value
·Fair Value ₹1.71k 20.5% undervalued intrinsic discount
India's Shift To Branded Generics Will Expand Chronic Therapy Markets
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
India's Shift To Branded Generics Will Expand Chronic Therapy Markets
Key Takeaways Eris is poised for revenue and margin expansion due to its chronic therapy pipeline, branded generics focus, and strategic capacity additions. Market growth is supported by deeper doctor engagement, tier 2/3 city expansion, and execution of international export strategies.Read more
AN
₹1.71k
20.5% undervalued intrinsic discount
Fair Value
Revenue
15.55% p.a.
Profit Margin
23.34%
Future PE
30.03x
Price in 2029
₹2.43k
Trending Discussion
Recently Updated Narratives
AN
ERIS: New Diabetes Franchise And Probiotic Acquisition Will Drive Future Upside
Fair Value: ₹1.71k 20.5% undervalued intrinsic discount
4 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Eris Lifesciences Limited Key Details
Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
- 44.72
- 74.46%
- 19.89%
- 59.3%
About ERIS
- Founded
- 2007
- Employees
- 3354
- CEO
- WebsiteView website
Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally. The company offers various branded formulations in various therapeutic areas, such as anti–diabetes, cardiovascular, nutrition, dermatology, neuroscience, gynecology, nephrology, and oncology, as well as central nervous system, women’s health, and vitamins/minerals/nutrients. It also provides patient care services, including ambulatory blood pressure measurement, ambulatory electrocardiogram measurement, continuous glucose monitoring system, sleep study, and anti-natal care solutions. It offers its products through wholesale drug distributors, stockists, retail and e-commerce pharmacies. Eris Lifesciences Limited was incorporated in 2007 and is headquartered in Ahmedabad, India.
